| Zacks Company Profile for IDEXX Laboratories, Inc. (IDXX : NSDQ) |
|
|
| |
| • Company Description |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
Number of Employees: 11,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $656.73 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 527,168 shares |
| Shares Outstanding: 79.62 (millions) |
| Market Capitalization: $52,291.49 (millions) |
| Beta: 1.66 |
| 52 Week High: $769.98 |
| 52 Week Low: $356.14 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-2.05% |
-1.19% |
| 12 Week |
-8.03% |
-8.15% |
| Year To Date |
-2.93% |
-3.40% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
ONE IDEXX DRIVE
-
WESTBROOK,ME 04092
USA |
ph: 207-556-0300
fax: 207-556-4346 |
ir@robinhood.com |
http://www.idexx.com |
|
|
| |
| • General Corporate Information |
Officers
Jonathan J. Mazelsky - President; Chief Executive Officer and Director
Lawrence D. Kingsley - Chairman
Andrew J. Emerson - Executive Vice President; Chief Financial Officer
Irene Chang Britt - Director
Bruce L. Claflin - Director
|
|
Peer Information
IDEXX Laboratories, Inc. (ABMD)
IDEXX Laboratories, Inc. (DMDS)
IDEXX Laboratories, Inc. (CPWY.)
IDEXX Laboratories, Inc. (EQUR)
IDEXX Laboratories, Inc. (ECIA)
IDEXX Laboratories, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45168D104
SIC: 2835
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/07/26
|
|
Share - Related Items
Shares Outstanding: 79.62
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.66
Market Capitalization: $52,291.49 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $3.44 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $14.54 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: 11.32% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 05/07/26 |
|
|
|
| |
